Navigation Links
FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): TGF-β Superfamily: Signaling in Development and Disease.

The 2013 "TGF-β Superfamily: Signaling in Development and Disease" is an important and unique scientific conference where the pivotal role of TGF- family members in developmental and homeostatic processes is explored through formal talks, poster sessions, and interactive and intensive scientific discussion sessions. The sessions are organized in different themes and are all held in an intimate setting with a limited number of participants.

This meeting includes outstanding researchers from around the world presenting diverse, cutting edge and forward looking research directed towards a fundamental understanding of the mechanisms of TGF-β family signaling: how these factors coordinate developmental processes, how aberrations in this signaling pathway lead to developmental abnormalities and human disease pathologies, and how this knowledge may come to be applied in the clinic.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
2. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
3. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
4. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
5. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
6. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
7. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
8. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
9. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
10. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
11. FASEB SRC announces conference registration open for: Neural Mechanisms in Cardiovascular Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... 23, 2017 , ... David Nolte, PhD accepted Purdue University’s ... Purdue Research Park of West Lafayette, Indiana. , The top commercialization award ... and success with, commercializing discoveries from Purdue research. “This award is truly an ...
Breaking Biology Technology: